allogeneic natural killer cell therapy (Cure Therapeutics)

N/A

Report date: 2025/06/11 10:38:26

Base Information

Drug Nameallogeneic natural killer cell therapy (Cure Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells stimulantsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsBreast NeoplasmsMultiple MyelomaGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCure Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesCure Therapeutics
Inactive CompaniesN/A
Active IndicationsBreast NeoplasmsMultiple MyelomaGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A